TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.

Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.